Affinage

CLCN4

H(+)/Cl(-) exchange transporter 4 · UniProt P51793

Length
760 aa
Mass
84.9 kDa
Annotated
2026-06-09
32 papers in source corpus 19 papers cited in narrative 19 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CLCN4 encodes ClC-4, a secondary active Cl-/H+ antiporter that drives endosomal acidification and supports recycling-endosome function (PMID:16034421, PMID:19339555). Originally characterized as a strongly outwardly rectifying anion conductance in heterologous systems (PMID:9873029, PMID:12668439), ClC-4 was redefined as a 2Cl-:1H+ exchanger in which the pore glutamate (E211) couples proton movement to chloride flux, since its mutation abolishes H+ transport while sparing Cl- transport (PMID:16034421). In endosomal membranes ClC-4 acidifies the endosomal lumen to permit iron dissociation from transferrin and proper transferrin-receptor recycling, a function established in Clcn4-null fibroblasts that show alkaline endosomes and a desferrioxamine-rescuable uptake defect specific to recycling endosomes rather than lysosomal EGFR trafficking (PMID:19339555). ClC-4 additionally promotes copper incorporation into ceruloplasmin in association with the Wilson's-disease protein ATP7B (PMID:15057754). ClC-4 is largely monomeric with an N-terminal ER-retention motif (residues 14-63) that confines it to the ER until heterodimerization with ClC-3 redirects it to recycling or late endosomes/lysosomes (PMID:17023393, PMID:28972156); its transport activity is further suppressed by the accessory protein TMEM9B (PMID:39202776). Disease-causing CLCN4 variants act through distinct mechanisms — loss-of-function via positive shifts in voltage-dependent activation, toxic gain-of-function permitting inward transport at negative voltages, impaired ClC-3 heterodimerization, and dominant-negative suppression of wild-type ClC-3 within heterodimers — all converging on disrupted endo-lysosomal ion homeostasis and neuronal dysfunction (PMID:36385166, PMID:41439993, PMID:33951195).

Mechanistic history

Synthesis pass · year-by-year structured walk · 11 steps
  1. 1999 High

    Established that ClC-4 itself forms the anion conduction pathway rather than acting as a regulatory subunit, by showing the protein directly mediates outwardly rectifying anion currents whose selectivity is altered by pore mutation.

    Evidence Heterologous expression and patch-clamp with E224A mutagenesis in Xenopus oocytes and HEK293 cells

    PMID:9873029

    Open questions at the time
    • Did not resolve whether ClC-4 is a channel or transporter
    • No physiological substrate or localization defined
  2. 2002 High

    Defined the biophysical fingerprint of ClC-4 as a small-conductance, nucleotide- and pH-sensitive outwardly rectifying conductance, characterizing its regulatory dependencies.

    Evidence Whole-cell and single-channel patch-clamp with nucleotide substitution in three mammalian cell lines

    PMID:11882671

    Open questions at the time
    • ATP requirement mechanism unresolved
    • Interpreted as a channel before transporter model emerged
  3. 2003 Medium

    Linked ClC-4 to endosomal physiology by localizing it to endosomes and showing its depletion alters endosomal pH and transferrin trafficking, and reported co-IP with ClC-5.

    Evidence Confocal microscopy, antisense knockdown, endosomal pH and transferrin assays, and co-immunoprecipitation

    PMID:12746443

    Open questions at the time
    • ClC-5 interaction not reciprocally validated
    • Single lab; direction of pH change vs transport mechanism unclear at the time
  4. 2005 High

    Reclassified ClC-4 from a classical chloride channel to a secondary active Cl-/H+ antiporter and pinpointed the pore glutamate E211 as essential for proton coupling.

    Evidence Surface pH measurements during heterologous expression with E211A pore-glutamate mutagenesis in Xenopus oocytes

    PMID:16034421

    Open questions at the time
    • Exact stoichiometry not defined in this finding
    • Structural basis of coupling not resolved
  5. 2006 High

    Identified an N-terminal ER-targeting motif (residues 14-63) that explains why ClC-4 is retained in the ER, establishing a trafficking determinant.

    Evidence Heterologous expression, subcellular fractionation of endogenous protein, and N-terminal truncation/chimera constructs

    PMID:17023393

    Open questions at the time
    • How the motif is overridden for endosomal delivery not yet known
    • Partner mediating exit not identified
  6. 2009 High

    Provided genetic proof that ClC-4 is required for endosomal acidification driving iron release from transferrin, with specificity for recycling endosomes.

    Evidence Clcn4 knockout mouse fibroblasts with endosomal pH, transferrin uptake, EGFR trafficking assays, and iron-chelator rescue

    PMID:19339555

    Open questions at the time
    • Did not address neuronal phenotypes
    • Trafficking route to endosomes not mechanistically explained
  7. 2017 High

    Resolved the trafficking determinant question by showing ClC-4 is monomeric and depends on heterodimerization with ClC-3 to escape the ER and reach endosomal compartments.

    Evidence Heterologous co-expression, native gel electrophoresis, and Clcn3 knockout astrocytes

    PMID:28972156

    Open questions at the time
    • Structural interface of the heterodimer not defined
    • Relative in vivo abundance of homo- vs heterodimers unknown
  8. 2022 High

    Systematically classified disease variants into mechanistic categories, distinguishing loss-of-function from toxic gain-of-function, framing genotype-mechanism relationships for CLCN4 disease.

    Evidence Two-electrode voltage-clamp of 59 missense variants in Xenopus oocytes; complementary characterization of additional variants in mammalian cells

    PMID:35721313 PMID:36385166

    Open questions at the time
    • Cellular consequences of each class not directly tested
    • Link to specific clinical severity incompletely mapped
  9. 2024 High

    Identified TMEM9B as the first accessory subunit regulator of ClC-4 that directly binds and suppresses its transport activity.

    Evidence Two-electrode and whole-cell patch-clamp with FLIM-FRET interaction measurement in oocytes and HEK cells

    PMID:39202776

    Open questions at the time
    • Physiological context of TMEM9B regulation in vivo unknown
    • Mechanism of activity suppression not resolved
  10. 2025 Medium

    Demonstrated that CLCN4 variants can act dominant-negatively by suppressing wild-type ClC-3 within heterodimers, explaining dominant disease inheritance.

    Evidence Voltage-clamp reconstitution of co-expressed ClC-3/ClC-4 via bicistronic constructs in oocytes and mammalian cells

    PMID:41439993

    Open questions at the time
    • Single lab
    • Endogenous-level dominant effect not confirmed in patient cells
  11. 2025 Low

    Began connecting CLCN4 dysfunction to neuronal-level phenotypes, linking variants to excitatory neuron loss, autophagic disruption, and altered network activity.

    Evidence Brain organoids and hiPSC-derived neurons with transcriptomics, autophagy assays, MEG3 rescue, and microelectrode array recordings (both preprints)

    PMID:bio_10.1101_2024.08.29.610281 PMID:bio_10.1101_2025.07.16.665078

    Open questions at the time
    • Preprints without independent replication
    • Mechanistic link from ion transport to MEG3/autophagy not established
    • Direction of expression change (loss vs gain) varies between models

Open questions

Synthesis pass · forward-looking unresolved questions
  • How endosomal Cl-/H+ exchange by ClC-4 is mechanistically translated into the cell-death, autophagy, and network-activity defects underlying neurodevelopmental disease remains unresolved.
  • No structural model of the ClC-3/ClC-4 heterodimer
  • Causal chain from ion homeostasis to neuronal phenotype unestablished
  • In vivo role of TMEM9B regulation unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005215 transporter activity 2 GO:0140096 catalytic activity, acting on a protein 1
Localization
GO:0005768 endosome 4 GO:0005783 endoplasmic reticulum 2 GO:0005764 lysosome 1 GO:0005886 plasma membrane 1
Pathway
R-HSA-1430728 Metabolism 2 R-HSA-382551 Transport of small molecules 2 R-HSA-5653656 Vesicle-mediated transport 2
Partners
ATP7BCFTRCLCN3CLCN5TMEM9B
Complex memberships
ClC-3/ClC-4 heterodimer

Evidence

Reading pass · 19 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2005 ClC-4 functions as a secondary active Cl-/H+ antiporter (not a classical Cl- channel), transporting protons across the membrane coupled to chloride flux. Mutation of the pore glutamate E211A abolished H+ transport but not Cl- transport, identifying this residue as essential for proton coupling. Extracellular pH measurements near cell surface during heterologous expression; pore glutamate mutagenesis (E211A) in Xenopus oocytes Nature High 16034421
1999 ClC-4 directly mediates strongly outwardly rectifying anion currents (NO3- > Cl- > Br- > I-) when expressed in Xenopus oocytes and HEK293 cells. Mutation E224A in ClC-4 alters voltage dependence and ion selectivity, confirming the protein directly forms the conduction pathway. Heterologous expression in Xenopus oocytes and HEK293 cells; patch-clamp electrophysiology; point mutagenesis The Journal of biological chemistry High 9873029
2003 ClC-4 is expressed in endosomal membranes of proximal tubule and cultured epithelial cells; antisense-mediated knockdown of ClC-4 acidified endosomal pH and altered transferrin trafficking. ClC-4 and ClC-5 can be co-immunoprecipitated, suggesting they partially function as a channel complex in endosomes. Confocal microscopy; antisense cDNA knockdown; endosomal pH measurement; transferrin trafficking assay; co-immunoprecipitation The Journal of biological chemistry Medium 12746443
2003 Human ClC-4 channels show voltage-dependent unitary current conductance (~0.10 pA at +140 mV) responsible for macroscopic outward rectification; conductivity and permeability sequences increase for anions with lower dehydration energies, defining unique pore properties distinct from other CLC isoforms. Whole-cell patch-clamp recordings; variance analysis; ion substitution experiments in HEK293/tsA201 cells Biophysical journal High 12668439
2002 Recombinant human ClC-4 encodes a small-conductance (~3 pS), nucleotide-dependent (ATP > ATPγS >> AMP-PNP), Ca2+-independent, outwardly rectifying chloride channel inhibited by extracellular acidification. ATP hydrolysis is required for full channel activity. Whole-cell and single-channel patch-clamp in three mammalian cell lines; nucleotide substitution experiments; pH manipulation The Journal of physiology High 11882671
2001 ClC-4 co-localizes with CFTR at the brush border membrane of intestinal epithelial cells and with endosomal markers EEA1 and transferrin; antisense knockdown of ClC-4 reduced endogenous chloride currents by 50%, demonstrating functional expression on the epithelial cell surface. Confocal and electron microscopy; antisense cDNA knockdown; patch-clamp electrophysiology in Caco-2 cells The Journal of biological chemistry Medium 11675385
2004 ClC-4 promotes copper incorporation into ceruloplasmin; overexpression of ClC-4 doubled copper incorporation while identical overexpression of ClC-3 had no effect. ClC-4 co-localizes with the Wilson's disease protein ATP7B in intracellular vesicles and physically associates with it by co-immunoprecipitation. Co-transfection/overexpression; gel electrophoresis and immunoblotting for holo/apoCeruloplasmin; co-immunoprecipitation; colocalization by microscopy Gastroenterology Medium 15057754
2006 Human ClC-4 localizes to the endoplasmic reticulum (ER) when expressed in HEK293 cells and skeletal muscle fibers; residues 14–63 at the N-terminus constitute a novel ER-targeting motif that is both necessary and sufficient for ER localization. Endogenous ClC-4 was identified in ER/SR membrane fractions from mouse brain. Heterologous expression in HEK293 cells and muscle fibers; confocal microscopy; subcellular fractionation; N-terminal truncations and chimeric constructs FASEB journal High 17023393
2008 Zn2+ inhibits human ClC-4 currents with ~50 µM apparent affinity via an extracellular binding site; mutagenesis identified three consecutive histidine residues in an extracellular loop as the Zn2+ binding site. Manipulations altering transport properties (permeant ion changes, gating glutamate mutation) dramatically affect Zn2+ inhibition, implicating this loop region in the transport mechanism. Two-electrode voltage-clamp in Xenopus oocytes; point mutagenesis of candidate residues; ion substitution experiments Biophysical journal Medium 18658230
2009 ClC-4-null fibroblasts show alkaline endosomal pH and reduced transferrin receptor-mediated uptake despite increased surface Tfn receptor expression; the uptake defect is rescued by the iron chelator desferrioxamine, indicating ClC-4 is specifically required for endosomal acidification that drives iron dissociation from transferrin. ClC-4 depletion had no effect on EGFR lysosomal trafficking, demonstrating specificity for recycling endosomes. Primary fibroblasts from Clcn4 knockout mice; endosomal pH measurement; transferrin uptake assay; EGFR trafficking assay; iron chelator rescue experiment Journal of cell science High 19339555
2017 ClC-4 is predominantly monomeric and has weaker homodimerization than ClC-3; co-expression with ClC-3 splice variants (ClC-3a/b or ClC-3c) redirects ClC-4 from ER retention to late endosome/lysosomes or recycling endosomes, respectively. In Clcn3−/− astrocytes, ClC-4 is retained in the ER, confirming ClC-3 is required for ClC-4 endosomal trafficking. Heterologous expression in HEK293T cells and cultured astrocytes; confocal microscopy; high-resolution clear native gel electrophoresis; Clcn3 knockout cells The Journal of biological chemistry High 28972156
2022 Electrophysiological analysis of 59 CLCN4 missense variants in Xenopus oocytes revealed two mechanistic classes: 25% (15/59) show loss-of-function via a positive shift in voltage-dependent activation, while 9 variants cause toxic gain-of-function via a disrupted gate permitting inward transport at negative voltages. Two-electrode voltage-clamp in Xenopus laevis oocytes; extended voltage and pH range protocols; systematic variant analysis Molecular psychiatry High 36385166
2022 Disease-associated CLCN4 variants produce a spectrum of functional consequences including gain/loss of function, impaired heterodimerization with ClC-3, and subtle transport impairments; even slight functional changes to endosomal Cl-/H+ exchange activity can cause neurological symptoms. Heterologous expression in mammalian cells; Western blot; confocal imaging; whole-cell patch-clamp electrophysiology; biochemical heterodimerization assays Frontiers in molecular neuroscience Medium 35721313
2024 TMEM9B physically interacts with ClC-4 (and ClC-3) and dramatically reduces their transporter activity when co-expressed. FLIM-FRET measurements confirmed direct interaction between TMEM9B and ClC-4, identifying TMEM9B as the first accessory subunit regulator of ClC-4. Two-electrode voltage-clamp in Xenopus oocytes; whole-cell patch-clamp in HEK cells; FLIM-FRET (fluorescence lifetime microscopy-based FRET) Life (Basel, Switzerland) High 39202776
2024 The CLCN4 variant p.(Gly342Arg) significantly impairs ClC-4 heterodimerization with ClC-3 and suppresses anion currents; p.(Ile549Leu) and p.(Asp89Asn) shift voltage dependency of activation by 20 mV (hyperpolarizing), with p.(Asp89Asn) producing gain-of-transport function. Patch-clamp electrophysiology; protein biochemistry; confocal fluorescence microscopy in mammalian cells Human genetics Medium 38578438
2025 Three CLCN4 disease variants exhibit dominant-negative effects within ClC-3/ClC-4 heterodimers, suppressing the transport activity of co-expressed wild-type ClC-3, providing the first evidence that CLCN4 variants can act dominantly through the heterodimer complex. Two-electrode voltage-clamp in Xenopus laevis oocytes; whole-cell patch-clamp in mammalian cells co-expressing ClC-3 and ClC-4 via bicistronic IRES construct Cells Medium 41439993
2025 CLCN4 variants reduce excitatory neuron numbers in brain organoids due to early-stage cell death, associated with altered endo-lysosomal dynamics and disrupted autophagic flux; lncRNA MEG3 is downregulated in CLCN4-variant neurons and restoring MEG3 expression rescues cellular defects and improves neuronal survival. Brain organoids and neuronal cell systems from CLCN4 patient-relevant variants; transcriptomic profiling; autophagic flux assays; MEG3 rescue experiments bioRxiv (preprint)preprint Low bio_10.1101_2025.07.16.665078
2025 Knockdown of CLCN4 in KdVS hiPSC-derived neurons restored network burst rate to control levels, confirming a causal relationship between elevated CLCN4 expression and reduced neuronal network burst rate. CLCN4 knockdown in hiPSC-derived neurons; microelectrode array (MEA) recordings; MEA-seq integrative framework bioRxiv (preprint)preprint Low bio_10.1101_2024.08.29.610281
2021 All evaluated CLCN4 variants in patients with epilepsy resulted in loss-of-function with reduced ClC-4 currents as assessed by electrophysiology; frameshift/intragenic deletion/inherited variants were associated with milder phenotypes while missense/de novo variants led to more severe phenotypes. Western blot; immunofluorescence; electrophysiological measurements in heterologous expression; clinical variant classification Epilepsia Medium 33951195

Source papers

Stage 0 corpus · 32 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2005 Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 377 16034421
1999 Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents. The Journal of biological chemistry 209 9873029
2003 The chloride channel ClC-4 contributes to endosomal acidification and trafficking. The Journal of biological chemistry 85 12746443
1995 Different chromosomal localization of the Clcn4 gene in Mus spretus and C57BL/6J mice. Nature genetics 72 7670496
2016 De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females. Molecular psychiatry 57 27550844
2003 Anion permeation in human ClC-4 channels. Biophysical journal 49 12668439
2002 Functional characterization of recombinant human ClC-4 chloride channels in cultured mammalian cells. The Journal of physiology 48 11882671
2001 The chloride channel ClC-4 co-localizes with cystic fibrosis transmembrane conductance regulator and may mediate chloride flux across the apical membrane of intestinal epithelia. The Journal of biological chemistry 47 11675385
2009 Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease. Nephron. Physiology 28 19546591
2022 Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition. Molecular psychiatry 27 36385166
2006 The human ClC-4 protein, a member of the CLC chloride channel/transporter family, is localized to the endoplasmic reticulum by its N-terminus. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 27 17023393
2004 Involvement of chloride channels in hepatic copper metabolism: ClC-4 promotes copper incorporation into ceruloplasmin. Gastroenterology 27 15057754
2021 The molecular and phenotypic spectrum of CLCN4-related epilepsy. Epilepsia 25 33951195
2017 Preferential association with ClC-3 permits sorting of ClC-4 into endosomal compartments. The Journal of biological chemistry 24 28972156
2009 An essential role for ClC-4 in transferrin receptor function revealed in studies of fibroblasts derived from Clcn4-null mice. Journal of cell science 21 19339555
2011 Clcn4-2 genomic structure differs between the X locus in Mus spretus and the autosomal locus in Mus musculus: AT motif enrichment on the X. Genome research 18 21282478
2008 Insights into the ClC-4 transport mechanism from studies of Zn2+ inhibition. Biophysical journal 16 18658230
2022 Functional Characterization of CLCN4 Variants Associated With X-Linked Intellectual Disability and Epilepsy. Frontiers in molecular neuroscience 13 35721313
2021 Novel CLCN4 variant associated with syndromic X-linked intellectual disability in a Chinese girl: a case report. BMC pediatrics 12 34479510
2025 Developmental deficits, synapse and dendritic abnormalities in a Clcn4 KO autism mice model: endophenotypic target for ASD. Translational psychiatry 9 39863599
2023 Whole exome sequencing identified five novel variants in CNTN2, CARS2, ARSA, and CLCN4 leading to epilepsy in consanguineous families. Frontiers in genetics 8 37359369
2024 TMEM9B Regulates Endosomal ClC-3 and ClC-4 Transporters. Life (Basel, Switzerland) 7 39202776
2023 Novel variants in the CLCN4 gene associated with syndromic X-linked intellectual disability. Frontiers in neurology 6 37789889
2024 Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy. Human genetics 5 38578438
2024 Expanding the genetic and phenotypic relevance of CLCN4 variants in neurodevelopmental condition: 13 new patients. Journal of neurology 4 38758281
2024 Experience with the Ketogenic Diet in a Boy with CLCN4 Related Neurodevelopmental Disorder. Balkan journal of medical genetics : BJMG 2 38482266
2023 Developmental and epileptic encephalopathy in a young Italian woman with a de novo missense variant in the CLCN4 gene: A case report. Brain & development 2 37271660
2023 Prenatal diagnosis of CLCN4-related neurodevelopmental disorder in fetuses with congenital brain anomalies. Prenatal diagnosis 2 37409888
2023 Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer. Aging 1 37671947
2025 Clinical features and genetic analysis of epilepsy caused by CLCN4 gene mutation: a case report and literature review. Translational pediatrics 0 40800199
2025 Dominant Action of CLCN4 Neurodevelopmental Disease Variants in Heteromeric Endosomal ClC-3/ClC-4 Transporters. Cells 0 41439993
2023 [Analysis of CLCN4 gene variant in a child with Raynaud-Claes syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 0 37730231

Missed literature

Know a paper Affinage missed for CLCN4? Flag it for the maintainers and the community.

No submissions yet.